Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
The industrial biotechnology firm Metabolix has filed with the Securities & Exchange Commission for an initial public offering that it hopes will raise as much as $86.3 million. Archer Daniels Midland has agreed to purchase $7.5 million in Metabolix common stock. ADM and Metabolix have plans to build a plant that will make polyhydroalkanoate plastics via fermentation. Metabolix is also working on a biorefinery system to produce PHA and biomass feedstock for ethanol. Metabolix reported revenue of about $2.8 million in 2005 and a net loss of about $7.6 million.
This article has been sent to the following recipient: